Mission

IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions.

Join IDEOM

To become a stakeholder with IDEOM, participation in Delphi surveys, web conferences, workgroups, and in-person meetings will be required. PLEASE APPLY HERE

Interested in creating a workgroup?
SUBMIT YOUR APPLICATION HERE

A Note From Our President:

"The true finish line is when the patient gets to the right doctor and the right treatment and their disease has minimal to no impact on their quality of life."

-Alice Gottlieb, MD, PhD

Welcome to the International Dermatology Outcome Measures

International Dermatology Outcome Measures is a non-profit organization seeking to develop and validate measures throughout dermatology with an initial focus on psoriatic disease. IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Launched in 2013, IDEOM seeks to bring together physicians, researchers, government agencies, pharmaceutical companies, payers and patients from around the globe to develop and validate measures throughout the field of dermatology with an initial focus on psoriasis.

To become a stakeholder with IDEOM, participation in Delphi survey's, web conferences, workgroups, and in-person meetings will be required. PLEASE APPLY HERE

Why Join IDEOM?

Join a community of like-minded researchers and stakeholders as we work for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Learn the facts...

A Prayer for IDEOM

Adapted from the Mishkan T'Filah,: A Reform Siddur. Central Conference of American Rabbis, New York, 2007.

UPCOMING EVENTS

The 6th World Psoriasis
& Psoriatic Arthritis Conference

June 30 – July 3, 2021
Learn More...

2021 IDEOM
Annual Meeting

October 22-23, 2021

Request for Application -
HS Grants

IDEOM is now accepting applications for IDEOM is seeking grant applications that encourage research into the disease hidradenitis suppurativa (HS). The goal is to stimulate the development of new research programs in the field of HS capable of competing for long-term funding from the National Institutes of Health or other agencies in the future. All interested should apply today!

LETTER OF INTENT DEADLINE: April 1, 2021
APPLICATION DEADLINE: August 1, 2021